Brief: Coya Therapeutics Increased Size Of Board To Six Directors From Five With Weinand's Appointment
21/08/2023 23:01
Aug 21 (Reuters) - Coya Therapeutics Inc COYA.O :
* COYA THERAPEUTICS INC: ON AUGUST 18, INCREASED SIZE OF
BOARD TO
SIX DIRECTORS FROM FIVE WITH WEINAND'S APPOINTMENT
Source text for Eikon: ID:
Further company coverage: COYA.O
(Reporting by Zaheer Kachwala)
((Zaheer.Kachwala@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)